Exome sequencing of cell-free DNA from metastatic cancer patients identifies clinically actionable mutations distinct from primary disease
Timothy M. Butler, Katherine Johnson-Camacho, Myron Peto, Nicholas J. Wang, Tara A. Macey, James E. Korkola, Theresa M. Koppie, Christopher L. Corless, Joe W. Gray, Paul T. Spellman
Dive into the research topics of 'Exome sequencing of cell-free DNA from metastatic cancer patients identifies clinically actionable mutations distinct from primary disease'. Together they form a unique fingerprint.